The efficacy of topical sodium pentaborate formulation on hemorrhoid disease: A randomized, double-blind, placebo-controlled trial.

Autor: Şahin F; Department of Genetics and Bioengineering, Faculty of Engineering, Yeditepe University, Istanbul, Turkey., Farshbaf-Khalili A; Physical Medicine and Rehabilitation Research Center, Aging Research Institute, Tabriz University of Medical Science, Tabriz, Iran., Alihosseini S; Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran., Sarbakhsh P; Department of Statistics and Epidemiology School of Public Health, Tabriz University of Medical Sciences, Tabriz, Iran., Pirouzpanah MS; Faculty of Medicine, Research & Development Office, Satin Tan Kimia co, Pharmaceutical Incubator, Tabriz University of Medical Sciences, Tabriz, Iran., Ayşan E; Faculty of Medicine, Department of General Surgery, Yeditepe University, Istanbul, Turkey., Doğan A; Department of Genetics and Bioengineering, Faculty of Engineering, Yeditepe University, Istanbul, Turkey., Gharekhani A; Drug Applied Research Center, Sina Hospital, Department of Clinical Pharmacy (Pharmacotherapy), Tabriz University of Medical Sciences, Tabriz, Iran., Khoshbaten M; Liver and Gastrointestinal Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran., Pirouzpanah MB; Stem Cell and Regenerative Medicine Institute, Tabriz University of Medical Sciences, Tabriz, Iran.

Publikováno v: Heliyon [Heliyon] 2024 Feb 29; Vol. 10 (5), pp. e27215. Date of Electronic Publication: 2024 Feb 29 (Print Publication: 2024).

The Preventive Effects of Boron-Based Gel on Radiation Dermatitis in Patients Being Treated for Breast Cancer: A Phase III Randomized, Double-Blind, Placebo-Controlled Clinical Trial.

Autor: Sahin F; Physical Medicine and Rehabilitation Research Center, Aging Research Institute, Tabriz University of Medical Sciences, Tabriz, Iran.; Department of Genetics and Bioengineering, Faculty of Engineering, Yeditepe University, Istanbul, Turkey., Pirouzpanah MB; Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran., Bijanpour H; Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran., Mohammadzadeh M; Department of Radiation Oncology, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran., Eghdam Zamiri R; Department of Radiation Oncology, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran., Ghasemi Jangjoo A; Department of Radiation Oncology, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran., Nasiri B; Department of Radiation Oncology, Tabriz International Hospital, Tabriz, Iran., Saboori H; Department of Radiation Oncology, Tabriz International Hospital, Tabriz, Iran., Doğan A; Department of Genetics and Bioengineering, Faculty of Engineering, Yeditepe University, Istanbul, Turkey., Demirci S; Cellular and Molecular Therapeutics Branch, National Heart Lung and Blood Institutes and National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA., Ayşan E; Faculty of Medicine, Department of General Surgery, Yeditepe University, Istanbul, Turkey., Çağrı Büke A; Department of Infectious Diseases, Yeditepe University Hospital, Yeditepe University, Istanbul, Turkey., Naseri AR; Department of Radiation Oncology, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran., Shakouri SK; Physical Medicine and Rehabilitation Research Center, Aging Research Institute, Tabriz University of Medical Sciences, Tabriz, Iran., Aghamohammadi D; Physical Medicine and Rehabilitation Research Center, Aging Research Institute, Tabriz University of Medical Sciences, Tabriz, Iran., Alizade-Harakiyan M; Department of Radiation Oncology, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran., Seyed Nejad F; Physical Medicine and Rehabilitation Research Center, Aging Research Institute, Tabriz University of Medical Sciences, Tabriz, Iran.; Department of Radiation Oncology, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.; Department of Radiation Oncology, Tabriz International Hospital, Tabriz, Iran.

Publikováno v: Oncology research and treatment [Oncol Res Treat] 2022; Vol. 45 (4), pp. 197-204. Date of Electronic Publication: 2022 Jan 03.

Silibilin-induces apoptosis in breast cancer cells by modulating p53, p21, Bak and Bcl-XL pathways.

Autor: Pirouzpanah MB; International Branch of Tabriz University of Medical Sciences (Aras), Tabriz, Iran E-mail : drnsamadi@yahoo.com., Sabzichi M, Pirouzpanah S, Chavoshi H, Samadi N

Publikováno v: Asian Pacific journal of cancer prevention : APJCP [Asian Pac J Cancer Prev] 2015; Vol. 16 (5), pp. 2087-92.